Federation des caisses Desjardins du Quebec’s Aratana Therapeutics, Inc. PETX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-600	Closed	-$2.55K	–	2222
2018 Q2	$2.55K	Hold	600	–	–	﹤0.01%	1991
2018 Q1	$2.65K	Hold	600	–	–	﹤0.01%	1972
2017 Q4	$3.16K	Hold	600	–	–	﹤0.01%	1946
2017 Q3	$3.68K	Hold	600	–	–	﹤0.01%	1883
2017 Q2	$4.34K	Hold	600	–	–	﹤0.01%	1906
2017 Q1	$3.18K	Buy	+600	New	+$4.05K	﹤0.01%	1609

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PETX Position: Q3 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2018, closing a stake of 600 shares — an estimated $2.55K sold.

Federation des caisses Desjardins du Quebec first reported a position in PETX in Q1 2017 and held it in 6 quarters. The position peaked at $4.34K in Q2 2017. 100 funds tracked by Wall St. Rank hold PETX as of Q3 2018.

Federation des caisses Desjardins du Quebec reported no remaining Aratana Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 600 Aratana Therapeutics, Inc. shares in Q3 2018, an estimated $2.55K.
Federation des caisses Desjardins du Quebec first reported a position in Aratana Therapeutics, Inc. in Q1 2017 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Aratana Therapeutics, Inc. position peaked at $4.34K in Q2 2017.
100 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2018, filed 30 Aug 2024.